| Cas No.: | 210345-04-3 |
| Chemical Name: | methyl (4S)-5-[[(2S)-1-[[(3S)-5-fluoro-1-methoxy-1,4-dioxopentan-3-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-4-[[(2S)-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-5-oxopentanoate |
| Synonyms: | Z-LE(OMe)HD(OMe)-FMK, Z-Leu-Glu(OMe)-His-Asp(OMe)-FMK, Z-Leu-Glu(OMe)-His-Asp(OMe)-Fluoromethylketone |
| SMILES: | CC(CC(NC(OCC1=CC=CC=C1)=O)C(NC(C(NC(C(NC(C(CF)=O)CC(OC)=O)=O)CC2=CN=CN2)=O)CCC(OC)=O)=O)C |
| Formula: | C32H43FN6O10 |
| M.Wt: | 690.72 |
| Purity: | >98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | Cell permeable fluoromethyl ketone (FMK)-derivatized peptides act as effective irreversible Caspase inhibitors with no cytotoxic effects and, there Fore, are useful tools For studying Caspase activity.For the detailed information of Z-LEHD-FMK, the solubility of Z-LEHD-FMK in water, the solubility of Z-LEHD-FMK in DMSO, the solubility of Z-LEHD-FMK in PBS buffer, the animal experiment (test) of Z-LEHD-FMK, the cell expriment (test) of Z-LEHD-FMK, the in vivo, in vitro and clinical trial test of Z-LEHD-FMK, the EC50, IC50,and Affinity of Z-LEHD-FMK, Please contact DC Chemicals. |

To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
